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Abstract
Cold-inducible RNA binding protein (CIRBP) has been reported to be associated with distinct tumorigenesis. In this
study, we investigated the role of CIRBP in human bladder cancer (BCa), indicating that CIRBP is overexpressed in BCa
tissues and cell lines to promote proliferation and migration. Moreover, CIRBP could induce expression of HIF-1α via
binding to the 3′-UTR of its mRNA to increase the mRNA stability in BCa cells. Furthermore, we demonstrated that
PTGIS is a HIF-1α targeted gene, a major regulator in hypoxic cancer progression by activating transcription of various
oncogenes. Our results also suggested that overexpression of HIF-1α may suppress the expression of PTGIS in BCa
cells, by binding to HRE sequence at the promoter region of PTGIS. In addition, we found a strongly downregulation of
PTGIS in BCa tissue and transcriptionally inhibited by HIF-1α in BCa cells, which could be triggered by its DNA
methylation. Further result suggested that knockdown of CIRBP could promote the expression of PTGIS, meanwhile
knockdown of PTGIS could partially rescue CIRBP-deﬁciency induced inhibition of migration and proliferation in BCa
cells. Taken together, our study indicated that CIRBP could be a novel oncogene in human bladder cancer inducing
transcription of HIF-1α, which could inhibit expression of methylated PTGIS.
Introduction
Bladder cancer (BCa) is the ninth most common
malignancy worldwide, with an estimated 429,000 new
cases and 165,000 deaths per year in the world1. Recent
studies have evaluated key molecular pathways of BCa,
such as RAS–mitogenactivated protein kinase (MAPK)
pathway, Wnt/β-catenin signaling pathway, and
epithelial–mesenchymal transition (EMT)2. Cold-
inducible RNA binding protein (CIRBP) was originally
identiﬁed in the testis as a mammalian cold shock pro-
tein3, and is induced by cellular stresses such as UV
radiation, cold and hypoxia3–6. CIRBP has been reported
to be overexpressed in several human tumors, such as
prostate, colon, breast and skin carcinomas7–9. Recent
mechanistic studies show that CIRBP displayed the ability
to bypass replicative senescence through activation of the
ERK1/2 signaling pathway in primary mouse embryonic
ﬁbroblasts7, further evidence for CIRBP’s oncogenic
function is that CIRBP promotes the development of liver
cancer by increasing ROS accumulation and CD133
expression10. However, the involvement of CIRBP in BCa
has not yet been investigated.
Recent studies describe that the stabilization of mRNAs
by speciﬁc RNA binding proteins (RBPs) can affect the
rate of translation in response to stress4,11 or extracellular
signals12. Recently, several important studies13,14 have
reported that Y-box binding protein 1, an RNA-binding
protein, enhances HIF-1α protein expression by directly
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binding to and activating translation of HIF-1A messages.
CIRBP is an RNA-binding protein and binds speciﬁcally
to the 3′-untranslated regions (3′-UTR) of many target
mRNAs4,15,16, and affects their post-transcription
expression. It was described that CIRBP can increase in
response to hypoxia by a HIF-1α-independent mechan-
ism6, moreover, our results demonstrate that CIRBP can
increase HIF-1α expression in BCa. In addition, Yang
et al. reported that HIF-1A is one of CIRBP-targeted
transcripts in the UniGene 3′-UTR data base15. These
results indicate that CIRBP may increase mRNA stability
and protein translation of HIF-1α by binding to the 3′-
UTR of its mRNA transcripts.
In human cancers, overexpression of HIF-1A in tumor
tissue compared with normal tissue has been revealed in
many human cancers17–20. Besides, Theodoropoulos et al.
reported that HIF-1A was overexpressed in BCa, and its
overexpression was related to poor prognosis21. More-
over, our qRT-PCR results using 20 pairs of BCa tissues
also showed that HIF-1A is upregulated in BCa tissues. As
a key regulator, HIF-1α target genes play major roles in
critical aspects of tumor biology. As a well-known HIF-1α
target gene, VEGF expression can be induced by HIF-1α
in many cancers, which can enhance vascular perme-
ability, stimulate angiogenesis, and increase local tissue
oxygenation22–24. Furthermore, HIF-1α target genes can
promote EMT, which include snail, transcription factor 3,
and zinc ﬁnger E-box-binding homeobox 1 and 2
(ZFHX1A, and ZFHX1B)25,26. Gene-expression array
demonstrate that more than 1,000 genes are transacti-
vated by HIFs in response to hypoxia27, Manalo et al.
reported that the PTGIS is an important target gene of
HIF-1α and may be directly regulated by HIF-1α28.
PTGIS encodes prostaglandin synthase (prostaglandin
I2 synthase), catalyzes the conversion of prostglandin H2
to prostacyclin (prostaglandin I2, PGI2)29. In cancers,
many studies displayed that PGI2 can suppress pro-
liferation and metastasis by activating peroxisome-
proliferator-activated receptors (PPARs)30–32. Our
microarray analysis (GEO accession No. GSE76211) using
BCa tissues and normal bladder epithelium indicated that
PTGIS is signiﬁcantly downregulated in BCa tissues, and
further studies shows that overexpression of HIF-1A in
BCa cell line can decrease the expression of PTGIS by
binding the hypoxia response element (HRE) of its pro-
moter. Increasing evidences show that the methylation of
CpG sites in promoter regions affects the regulation of
gene expression by HIF-1α. It has been reported that
methylation free HIF-1α Binding Site is required in sev-
eral genes expression regulation by HIF-1α, such as
MUC17, S100A4 and Erythropoietin33–35. Recent resear-
ches reported that PTGIS promoter is hypermethylated in
colorectal cancer36,37, MethHc database (http://methhc.
mbc.nctu.edu.tw/php/index.php) shows that PTGIS has a
high DNA methylation levels in BCa. Therefore, we
speculate that DNA methylation could be the reason that
PTGIS expression is downregulated by HIF-1α but not
upregulated by it in BCa cell line.
Materials and methods
Human bladder tissue samples
Bladder cancer and paracancerous tissue samples (n=
20) were obtained from patients after surgery at
Zhongnan Hospital of Wuhan University, informed
consent was collected from all subjects, and the histol-
ogy diagnosis was conﬁrmed pathologically by two
pathologists independently. All the tissues were imme-
diately stored in liquid nitrogen or ﬁxed in 4% PFA after
collection from the operation room. The informed
consent was signed by all subjects. All specimens col-
lection and treatment were carried out in accordance
with the approved guidelines according to the Ethics
Committee at Zhongnan Hospital of Wuhan University
(approval number: 2015029).
Plasmid construction
CIRBP cDNA (518 bp) and PTGIS cDNA (1502 bp)
were polymerase chain reaction ampliﬁed from human
BCa cell lines cDNA library and both cloned into 2xFIag-
pcDNA3 empty vector, using CIRBP forward primer sense
EcoR1 5′-CGGAATTCATGGCATCAGATGAAGGC-3′;
CIRBP reverse primer sense Xho1 5′-AACTCGAGTT
ACTCGTTGTGTGTAGCGT-3′; PTGIS forward primer
sense BamH1 5′-TAGGATCCATGGCTTGGGCCGCGC
T-3′; PTGIS reverse primer sense EcoR5 5′-TCGA-
TATCTCATGGGCGGATGCGGTAGCG-3′; The DNA
sequence was veriﬁed by sequencing. p3xFlag-CMV-14-
HIF-1A plasmid was a gift from Dr. Zhongqiang Guo
(Department of Urology, Zhongnan Hospital of Wuhan
University). pGL4.10-PTGIS promoter plasmid and
pGL4.10-PTGIS promoter mut plasmid were purchased
from Obio Technology Corp. Ltd. (Shanghai, China).
Biotin-label mRNA transcripts were purchased from
GenePharma biotech company (Shanghai, China).
Cell culture, transfections, and stable cell lines selection
Human BCa cell lines 5637, UM-UC-3, T24 and human
epithelial SV40 immortalized uroepithelium cell line SV-
HUC-1 were obtained from the Stem Cell Bank, Chinese
Academy of Sciences in Shanghai, China. Human BCa cell
lines BIU-87 were purchased from the Procell Co., Ltd. in
Wuhan, China. The BCa cell lines were identiﬁed by the
China Centre for Type Culture Collection in Wuhan,
China. 5637, T24, SV-HUC-1, BIU-87 Cells were cultured
in RPMI-1640 medium (Gibco, China) and UM-UC-3
cells was cultured in DMEM high glucose medium
(Gibco, Australia), with 10% fetal bovine serum (FBS)
(Gibco, Australia) in 5% CO2 at 37℃.
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For transfection, cells were transfected with plasmids or
siRNA oligonucleotides using Lipofectamine 2000 trans-
fection reagent according to the manufacture’s protocol.
The sense sequence of CIRBP-siRNA (siCIRBP) / CIRBP-
shRNA (shCIRBP) was 5′-CCAGAGAUCUCGGGGAU
UUTT-3′, the sense sequence of control-siRNA (NC) /
control-shRNA (NC) was 5′-UUCUCCGAACGUGU-
CACGUTT-3′, and the sense sequence of HIF-1A-siRNA
(si HIF-1A) was 5′-GCCGCUCAAUUUAUGAAUATT-
3′, the sense sequence of PTGIS-siRNA (siPTGIS) was 5′-
GGCUGAAGAAUUACAACAUTT-3′.
For stable cell line selection, UM-UC-3 cells were
infected with lentiviral-CIRBP-shRNA and lentiviral-
control-shRNA (LV-NC) for 24 h, and treated by 5 μg/ml
puromycin (Sigma, USA) for 7 days for further selection.
Cell proliferation, clonogenic survival assay, and migration
Cell proliferation was performed by MTT assay. After
transfection for 48 h, BCa cells were plated into 96-well
plates (3000 cells per well) in 200 μl suspension medium
(RPMI-1640 medium or DMEM high glucose medium) to
grow for another 5 days. After indicated days, 20 μl MTT
solution (5 mg/ml) was added into each well and incu-
bated for 4 h at 37 °C. Absorbance at 490 m was measured
by Microplate reader (Cat. #SpectraMax M2, Molecular
Devices, USA).
For clonogenic survival assay, 48 h after transfection,
distinct BCa cells were seeded in 6-well plates (1000 cells
per well) and grew into colonies for approximately
14 days. The cells were washed gently twice with PBS and
ﬁxed in PBS with 4% freshly made paraformaldehyde for
30min and then stained by crystal violet. The number of
colonies was counted and statistically analyzed.
The transwell migration assay was conducted using 24-
well plates transwell chamber system (Corning, USA) with
8.0 µm pore size. Brieﬂy, 48 h after transfection, BCa cells
were seeded (3 × 10^4 cells per chamber) in 200 µl serum-
free medium in the upper transwell chamber (Corning,
USA), while the lower chamber was ﬁlled with 600 µl
medium containing 10% FBS. After incubation for 24 h at
37 °C, the cells on the upper chamber of ﬁlter were
removed, and the cells on the lower chamber were ﬁxed
with 4% PFA and stained by 0.1% crystal violet. Then the
chambers were placed under an inverted phase contrast
microscope, the number of cells was counted and pho-
tographed in three random ﬁelds.
RNA isolation and quantitative real-time PCR
Total RNA was isolated by HiPure Total RNA Mini Kit
(Magen, China) from BCa cells and bladder tissues,
quantity of isolated RNA was measured by NanoDrop.
The reverse transcription reaction was performed with
ReverTra Ace qPCR RT Kit (Toyobo, China). 1 µl of the
resulting cDNAs were used as templetes for each reaction
of the RT-PCR with iQTM SYBR® Green Supermix (Bio-
Rad, USA) in a ﬁnal volume of 20 µl. Primer sequences are
listed in Supplementary Table S1. Fold enrichment was
calculated with the −ΔΔCt method relative to GAPDH.
Total protein isolation, Western blot, and
immunoﬂuorescence staining
BCa cells were washed with PBS for three times and
lysed by RIPA buffer containing protease inhibitor and
phosphatase inhibitor (Sigma-Aldrich, USA) for 30 min
on ice. The cell lysates were then centrifuged at 13,000×g
for 15 min. The supernatants were collected and protein
concentration was determined by Bradford protein assay
(Bio-Rad, Germany). The isolated total protein samples
(25–30 μg) were separated by 6-15% SDSPAGE and sub-
jected to Western blot analysis. The immunoreactive
bands were visualized using an enhanced chemilumines-
cence kit (Bio-rad, USA) and detected by Molecular
Imager Chemi Doc XRS+ Imaging system (Bio-rad, USA).
The primary antibodies and secondary antibodies were
listed in Supplementary Table S2. Immunoﬂuorescence
staining for BCa cells seeded on 12mm coverslips and
ﬁxed tissue samples were accomplished by Biofavor Bio-
tech company (Wuhan, China), immunoﬂuorescence
staining was analysed by using a Confocal microscope
system (Nikon C2+ Confocal Microscope, Japan).
mRNA stability assay, cycloheximide (CHX) assay, RNA-
binding protein immunoprecipitation assay, and biotin
pull-down assay
In order to examine the effects of CIRBP on the stability
of the mRNAs of HIF-1A, 24 h after transfection, Cells
were pretreated with CoCl2 (100 μM, Sigma c8661) for 4
h, then Actinomycin D (15 μg/ml, Abcam ab141058) was
added to inhibit transcription. Total RNA was collected at
speciﬁc time points of 0, 2, 4, 6, 8 h, and RT-PCR detected
mRNA levels of HIF-1A.
In order to examine the effects of CIRPR on HIF-1α
protein stability, 24 h post-transfection, Cells were pre-
treated with CoCl2 (100 μM) for 4 h, then cycloheximide
(200 µg/ml, MCE, HY-12320) was added inhibit protein
synthesis. Total protein samples were collected at speciﬁc
time points of 0, 2, 4 h, and Western blot detected protein
levels of HIF-1α.
For RNA-Binding Protein Immunoprecipitation (RIP)
assay, 24 h after transfection with CIRBP overexpression
plasmid, the cells on the plates were washed twice with
5 ml of ice-cold PBS, then lysed with1 ml lysis buffer
(150 mM NaCl, 1% IGEPAL CA-603, 0.5% DOC, 0.1%
SDS, 50 mM Tris 100 U/ml Rnasin, 1 mm PMSF) for 10
min, the cell lysates were then centrifuged at 16,000×g for
10 min and the supernatants were collected. 500 μl
supernatants were incubated with 100 μl Protein G
Sepharose beads (GE Healthcare Life Sciences, USA) with
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rotating for overnight which had been pre-coated with
40 μg of either anti-CIRBP or Normal rabbit anti-IgG1 for
6 h. The beads were washed ﬁve times (0.5 ml wash, 5 min
each) with Wash buffer (50mM Tris-HCl, 150mM NaCl,
1 mM MgCl2, 0.05% NP-40 and 100 U/ml Rnasin), bound
proteins were then digested by proteinase K Buffer
(adding 0.1% SDS and 0.5 mg/ml proteinase K) at 55 °C
for 30min. Total RNA was isolated by chloroform
extraction and resuspended in DEPC-treated water. RT-
PCR analyzed the mRNA levels of HIF-1A, then the IP
efﬁciency was calculated by percent of input (Percent
Input= 2% x 2(CT 2%Input Sample−CT IP Sample).
Biotin pull-down assays were performed by incubating
40 μg of cytoplasmic fractions with 50 pmol of biotin-label
mRNA transcripts for 1 h at room temperature, and the
ribonucleoprotein complexes were then isolated with
50 µl of streptavidin-conjugated Dynabeads (Invitrogen, #
11205D). The presence of CIRBP in the pull-down pellets
was veriﬁed using Western blot analysis.
Chromatin immunoprecipitation (ChIP) assay and
luciferase reporter assay
The ChIP assay was performed with Simple CHIP® Plus
sonication Chromation IP Kit (#56383, Cell Signaling
Technology, USA) and carried out according to the
manufacturer’s protocol. Brieﬂy, 24 h after transfection
with p3xFlag-CMV-14-HIF-1A plasmid or empty vector,
cells were Cross-linked in 37% formaldehyde, and scraped
into cold buffer, then continued with nuclei preparation
and chromatin digestion. DNA fragment size was deter-
mined by electrophoresis on a 1% agarose gel (approxi-
mately 100–1000 bp). Then cross-linked chromatin was
incubated with 2 μg anti-FLAG or normal rabbit IgG for
overnight at 4 °C with rotation. After washing the protein
G magnetic beads with low salt washing buffer and high
salt washing buffer, Chromatin was eluted from Anti-
body/Protein G Magnetic Beads, detected by quantitative
realtime PCR and calculate the IP efﬁciency (Percent
Input= 2% x 2(CT 2%Input Sample−CT IP Sample)), Primer
sequences for PTGIS promoter are listed in Supplemen-
tary Table S3.
For the luciferase reporter assay, cells were seeded onto
24-well plates and cotransfected with 500 ng of luciferase
reporter plasmids (pGL4.10-PTGIS promoter vector,
pGL4.10-PTGIS promoter mut vector or pGL4.10 base
vector), and 500 ng of HIF-1A expression vector or empty
vector. After 24 h, luciferase activity was measured with
Luc-Pair TM Duo-Luciferase Assay Kit 2.0 (GeneCopoeial
lnc, USA) according to its protocol.
Xenograft model and pulmonary metastasis model
Male BALB/c-nu mice (4-weeks old) were purchased
from Beijing Vital River Laboratory Animal Technology
Co., Ltd. (Beijing, China), and maintained in laboratory
animal facility of Zhongnan Hospital of Wuhan Uni-
versity. After adaptive feeding for a week, xenograft
models were established by subcutaneously inoculating
1 × 106 UM-UC-3 LV-NC cells or LV-CIRBP sh cells
diluted in100 µl PBS (n= 4), while pulmonary metastasis
models were established by tail intravenous injecting 1 ×
106 cells diluted in 100 µl PBS (n= 3). 6 weeks post
injection, the mice were sacriﬁced and the tumors were
taken out and weighed, meanwhile the tumor volume was
measured every 6 days (tumor volume= length × width ×
0.5 mm3). The ﬂuorescence of pulmonary metastasis
tumor was measured by FUSION FX7 Spectra Imaging
system (Vilber, France).
Statistical analyses
Data were expressed as mean ± SD from three indivi-
dual experiments, statistical analyses were performed with
SPSS Statistics 22.0. Unpaired 2-tailed T-test and one-way
analysis of variance were used to evaluate statistical sig-
niﬁcance of differences of data, p < 0.05 were considered
signiﬁcant.
Results
CIRBP acts as an oncogene during BCa progression
To investigate the CIRBP expression level in BCa,
CIRBP mRNA was analyzed by qRT-PCR analysis, indi-
cating no signiﬁcant difference in the BCa tissues com-
pared with the paired paracancerous tissues (n= 21,
Supplementary Figure S1A). We next analyzed the asso-
ciation between the CIRBP mRNA levels and the tumor
stage of these BCa tissues, indicating that CIRBP expres-
sion levels were positively correlated with the T stage in
BCa (Fig. 1a). Furthermore, Western blot analyzed the
protein level of CIRBP in 14 pairs of BCa tissues and
paracancerous tissues, CIRBP protein upregulation was
observed in 8 of 14 (57%) BCa tissues (Fig. 1b). To further
conﬁrm CIRBP protein upregulation, immuno-
ﬂuorescence staining was performed, CIRBP was observed
in the nucleus, and it revealed strong increase of CIRBP
protein in the BCa tissues (Fig. 1c). In addition, we
detected the CIRBP protein levels in four BCa cell lines
(5637, UM-UC-3, T24 and BIU-87) and immortalized
normal uroepithelial cell line (SV-HUC-1), exhibiting an
upregulation tendency of CIRBP in BCa cell lines (Fig. 1d).
To obtain further insight into the function of CIRBP,
we searched the gene function enrichment by
using miRNA Cancer MAP database (http://cis.hku.hk/
miRNACancerMAP/index.php). As shown in Fig. 1e, f,
CIRBP was signiﬁcantly enriched in several pathways,
such as RNA degradation, cell cycle, adherens junction.
To study the effects of CIRBP on the biological beha-
viors of BCa cells, an siRNA speciﬁcally targeting CIRBP
was used to knock down CIRBP expression, while an
CIRBP gene overexpression plasmid was used to
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upregulate CIRBP expression in two BCa cell lines (UM-
UC-3 and 5637). Western blot analysis veriﬁed the over-
expression and knockdown efﬁciencies, and qRT-PCR
analysis demonstrated the same results in mRNA levels
(Supplementary Figure S1B). Next, we evaluated the cell
proliferation and migration abilities. MTT assay showed
that CIRBP-siRNA-treated BCa cells grew signiﬁcantly
slower than the control BCa cells, conversely, over-
expression of CIRBP dramatically promoted cell growth
(Fig. 2a). In agreement with its facilitated proliferation
function, clonogenic survival assay revealed that the
ability of colony formation was signiﬁcantly decreased in
the CIRBP knockdown cells, while increased in CIRBP
overexpression cells (Fig. 2b). What’s more, transwell
migration assay suggested that knockdown of CIRBP in
BCa cells could reduce cell migration and overexpression
of CIRBP could induce cell migration (Fig. 2c).
Effects of CIRBP on MAPK signaling pathway and EMT
markers
MAPK pathway plays an important role in various
tumor physiological processes, including cell prolifera-
tion, cell differentiation and cell survival38,39, our tran-
scriptome data also indicated that MAPK signaling
pathways play a key role in BCa40,41. CIRBP has been
reported to be involved in multiple tumor progression via
Fig. 1 CIRBP protein is upregulated in 57% (8 of 14) BCa tissues and BCa cell lines, positively correlation between CIRBP expression levels
and the T stage BCa, and pathway enrichment of CIRBP. a qRT-PCR analysis of CIRBP levels in different T stage BCa tissues. bWestern blot analysis
of the protein level of CIRBP in 14 pairs of BCa tissues and paracancerous tissues, GAPDH was used as a loading control. c Representative
immunoﬂuorescence staining of CIRBP (green) in the BCa tissue comparing with the normal bladder tissue, nuclei were stained by DAPI (blue). The
images were photographed by Confocal microscope system. d Western blot analysis of CIRBP protein abundance in four BCa cell lines (5637, UM-UC-
3, T24 and BIU-87) and immortalized normal uroepithelial cell line (SV-HUC-1). e and f KEGG pathway enrichment and GO enrichment of CIRBP in
miRNA Cancer MAP database
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the activation of ERK and p38 MAPK7,42,43. Our Western
blot analysis showed phosphorylated ERK1/2 (p-ERK1/2)
and phosphorylated p38 (p-p38) protein levels were
obviously decreased in the si-CIRBP-treated 5637 cells,
whereas increased in the CIRBP overexpression UM-UC-
3 cells (Fig. 2d).
Moreover, because CIRBP could promote cell migra-
tion, and pathway enrichment indicated that CIRBP is
related with adherens junction, proteins involved in the
EMT process were analyzed by Western blot analysis.
CIRBP knockdown could suppress the expression of N-
cadherin, vimentin, β-catenin and snail in 5637 cells,
reversely, CIRBP overexpression could increase their
expression level in UM-UC-3 cells. In addition, knock-
down of CIRBP could upregulate the epithelial marker E-
cadherin in 5637 cells, and overexpression of CIRBP could
reduce E-cadherin protein expression in UM-UC-3 cells
(Fig. 2e).
Reduction of CIRBP inhibits BCa growth and pulmonary
metastasis in vivo
To verify the function of CIRBP in vivo, lentiviral-
CIRBP-shRNA and lentiviral-control-shRNA (LV-NC)
stable cell line were established, after selection with pur-
omycin for 7 days, the green ﬂuorescence of stable cell
lines was showed in Fig. 3a, qRT-PCR analysis validated
the Efﬁciency of CIRBP knockdown by lentiviral-CIRBP-
shRNA (Fig. 3a). Next, as shown in Fig. 3b, c, xenograft
models were construct, the LV-shCIRBP group grew sig-
niﬁcantly slower than the control group in vivo, and the
mean tumor weight was signiﬁcantly lower in the LV-
shCIRBP group than in the LV-NC group (Fig. 3c). The
dissected neoplasms tissues were embedded into parafﬁn,
the Hematoxylin and Eosin staining (HE staining) results
suggested the reduced number of tumor cells in the LV-
shCIRBP group, and the immune-ﬂuorescence staining
displayed that CIRBP expression is weaker in the LV-
Fig. 2 CIRBP promotes BCa cells proliferation and migration in vitro, increases the phosphorylation state of ERK1/2 and p38, also
promotes the EMT in BCa cells. a Distinct BCa cells (UM-UC-3 and 5637) transfected with NC (red), siCIRBP (brown), vector (green) or CIRBP
overexpression plasmid (blue) were allowed to grow at the indicated times, and Cell growth and viability were evaluated by MTT assay. b Clonogenic
survival assay evaluated Colony formation, and statistical analysis of the clone number. c Cell migration was evaluated by transwell migration assay,
and the relative cell number of migration was statistically analyzed. d Proteins in the MAPK family, including phosphorylated and total ERK1/2 and
p38, were analyzed by Western blot, suggesting activation of ERK1/2 and p38 by CIRBP in BCa cells. e Western blot analyzed the proteins (E-cadherin,
N-cadherin, Vimentin, β -catenin and snail) involved in EMT after 48 h transfection of siCIRBP in 5637 cells or CIRBP overexpression plasmid in UM-UC-
3 cells. Means ± standard deviation from three independent experiments. Student t test was used for statistical analysis
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shCIRBP group compared with the LV-NC group
(Fig. 3d).
In the same way, for the purpose of investigating the
effect of CIRBP knockdown on BCa metastasis in vivo,
pulmonary metastasis models were established by tail
intravenous injecting LV-shCIRBP UM-UC-3 cells or LV-
NC UM-UC-3 cells, after 4 weeks of injection, the ﬂuor-
escence of pulmonary metastasis tumor was measured to
evaluate the migration capacity. As exhibited in the
Fig. 3e, CIRBP knockdown could signiﬁcantly suppress
migration in vivo in contrast with the LV-NC group, the
HE staining displayed the pulmonary metastasis tumors
(pointed by the arrows).
CIRBP increases mRNA stability and protein translation of
HIF-1α in BCa cell line
To investigate the relationship between CIRBP and
HIF-1α in BCa, we ﬁrst evaluated whether HIF-1α could
modulate the expression of CIRBP, qRT-PCR analysis
showed that HIF-1A overexpression have no obvious
effect on the mRNA level of CIRBP (Supplementary Fig-
ure S1C). Next, the study addressed the effects of CIRBP
on HIF-1α expression, as shown in the Fig. 4a, qRT-PCR
analysis showed that both CIRBP knockdown and CIRBP
overexpression had no signiﬁcant effects on the mRNA
levels of HIF-1A. Moreover, Western blot analysis showed
that transfection of si-CIRBP could robustly downregulate
Fig. 3 Knockdown of CIRBP inhibits BCa growth and migration in vivo. a The green ﬂuorescence of stable cell lines, and qRT-PCR analysis
veriﬁcation of CIRBP knockdown efﬁciency by lentiviral-CIRBP-shRNA. b Xenograft models (n= 4) were established by subcutaneously inoculating LV-
NC cells or LV-shCIRBP cells and allowed to grow for 6 weeks, then the mice were sacriﬁced and the tumors were taken out and weighed. c tumor
volume measurement and tumor weight. d Representative H&E staining and immuneﬂuorescence staining of xenograft tumors from the tumor-
bearing mice of the LV-NC group and LV-shCIRBP group, indicating the downregulation of CIRBP (red) in LV-shCIRBP group. Nuclei were stained by
DAPI (blue). e Pulmonary metastasis models (n= 3) were established by tail intravenous injecting LV-shCIRBP UM-UC-3 cells or LV-NC UM-UC-3 cells,
the ﬂuorescence intensity of pulmonary metastasis tumor was measured to evaluate the migration capacity. Representative H&E staining of lung
tissues indicating the pulmonary metastasis tumors (pointed by the arrows). Statistical analysis of the ﬂuorescence intensity was calculated using T-
test. Means ± standard deviation from three independent experiments
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HIF-1α expression, and overexpression of CIRBP could
signiﬁcantly upregulate HIF-1α expression, both under
normoxia and hypoxia (Fig. 4b), the same results were
also revealed by immunoﬂuorescence staining under
normoxia (Fig. 4c).
UniGene database indicated that HIF-1A is one of
CIRBP-targeted transcripts15, and pathway enrichment
indicated that CIRBP was signiﬁcantly enriched in RNA
degradation and RNA stabilization. To determine whether
CIRBP upregulate HIF-1α expression through binding to
the 3′-UTR and increases its mRNA stability, we ﬁrst
performed mRNA stability experiments in the presence of
actinomycin D (a transcriptional inhibitor, 15 μg/ml), as
displayed in Fig. 4d, under the hypoxia conditions (pre-
treated with CoCl2 100 µM for 4 h), the results
demonstrated that transfection with si-CIRBP reduced the
stability of HIF-1A mRNA. While in absence of CoCl2,
CIRBP overexpression could increase HIF-1A mRNA
stability strikingly. Next, RNA-Binding Protein Immuno-
precipitation (RIP) assay was used to demonstrate that
CIRBP could bind to HIF-1A mRNA (Fig. 4e). Further-
more, biotin pull-down assay was achieved to conﬁrm the
interacts of CIRBP and HIF-1A mRNAs 3′-UTR, as
shown in Fig. 4f, substantial amounts of CIRBP were
associated with the HIF-1A mRNA transcripts 3’-UTR,
nevertheless, both the 5’-UTR of HIF-1A mRNA tran-
scripts and the negative control transcripts failed to pull
down CIRBP. In addition, in order to investigate the
effects of CIRBP on HIF-1α protein stability, cyclohex-
imide (CHX) assay was performed. As shown in
Fig. 4 CIRBP increases mRNA stability and protein translation of HIF-1α in BCa cells. a qRT-PCR analysis for the effects on the HIF-1A mRNA
levels of CIRBP knockdown and CIRBP overexpression. b Western blot analysis of HIF-1α performed on CIRBP knockdown and CIRBP overexpression
UM-UC-3 cells, exposed (+) or not (−) to CoCl2 (100 μM for 4 h, Sigma 15862). c Immunoﬂuorescence staining revealed alterations of HIF-1α (green)
after 48 h transfection of siCIRBP in UM-UC-3 cells or CIRBP overexpression plasmid in UM-UC-3 cells under normoxia (CIRBP red). Nuclei were stained
by DAPI (blue). d 24 h after transfection with siCIRBP (pretreated with CoCl2) or CIRBP overexpression plasmid (under normoxia), UM-UC-3 cells were
cultured in the presence of Actinomycin D (15 μg/ml, Abcam ab141058), qRT-PCR detected mRNA levels of HIF-1A speciﬁc time points of 0, 2, 4, 6 h.
GAPDH is used as the normalization control. e RNA-Binding Protein Immunoprecipitation (RIP) assay was performed with anti-CIRBP or anti-IgG, qRT-
PCR detected the IP efﬁciency (percent input). f Biotin pull-down assay was achieved to conﬁrm the interacts of CIRBP and HIF-1A mRNAs 3′-UTR,
both 3′-UTR and 5′-UTR of HIF-1A mRNA transcripts were constructed with biotin-label, transcripts of GAPDH mRNA were used as a negative control.
Means ± standard deviation from three independent experiments. T-test was used for statistical analysis
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Supplementary Figure S1D, CIRBP knockdown had no
obvious effects on the HIF-1α protein degradation.
PTGIS is a HIF-1α target gene in BCa
As a master regulator in hypoxic cancer progression,
HIF-1α activates transcription of many genes23, two
publications of microarray hybridization analysis have
reported that PTGIS is an important target gene of HIF-
1α28,44, and our microarray analysis (GEO accession no.
GSE76211) indicate that PTGIS is a signiﬁcantly down-
regulated gene in BCa tissues compared with normal
bladder tissues. Therefore, our following studies focused
on the regulatory effects of HIF-1α on PTGIS expression
in BCa. In the same way, we ﬁrst detected the mRNA
levels of HIF-1A and PTGIS in the BCa tissues (n= 20),
the results of qRT-PCR analysis displayed that HIF-1A is
signiﬁcantly upregulated, while PTGIS is remarkably
downregulated in the BCa tissues (Fig. 5a). Furthermore,
to detect the transcription effects of HIF-1α on PTGIS
expression, a HIF-1A gene overexpression plasmid was
used, as shown in Fig. 5b, overexpression of HIF-1α could
suppress the expression of PTGIS both in mRNA level
and protein level, immunoﬂuorescence staining also
proved the same conclusion. In addition, HIF-1A knock-
down with a siRNA speciﬁcally targeting HIF-1A could
increase the PTGIS mRNA level (Supplementary Fig-
ure S1E), the overexpression and knockdown efﬁciencies
were validated by qRT-PCR (Supplementary Figure S1E).
As a key transcription factor of the adaptive response to
hypoxia, HIF-1α transcriptional regulates many genes
through binding to core DNA sequence 5’-RCGTG-3’
within the HRE of target gene promoters45. We next
predicted an HRE binding site (5′-ccACGTGc-3′) of HIF-
1α on PTGIS promoter region through using GCBI
database (https://www.gcbi.com.cn/gclib/html/index), in
addition, as shown in Fig. 5d, the binding site of HIF-1α
provided by the JASPAR database (http://jaspardev.
genereg.net/) supported this conclusion. Furthermore, a
ChIP assay was performed to verify this conclusion, after
transfection for 24 h, DNA was digested with ultraphonic
to a length of approximately 100-1000 bp (Supplementary
Figure S1F), and the anti-FLAG was employed to pull
down HIF-1α and its associated DNA fragments. As
shown in Fig. 5c, seven pairs of primers were designed to
cover the region of the PTGIS promoter, qRT-PCR
detected the enrichment results. And the highest enrich-
ment of FLAG-HIF-1A was identiﬁed at the P3 region of
the PTGIS promoter, followed by the P2 and P4 region,
while no signiﬁcant enrichment was found in other
regions (Fig. 5e). Subsequently, luciferase reporter assay
was used to evaluate the effects of HIF-1α on PTGIS
promoter activity, as shown in Fig. 5f, overexpression of
HIF-1A could obviously enhance the luciferase activity of
PTGIS luc compared with empty vector, while mutant of
HRE (5′-ccTGCACc-3′) sequence could signiﬁcantly
reduce this induction.
CpG Methylation of PTGIS promoter region plays an
important role in transcriptional regulation of HIF-1α
CpG methylation plays an important regulatory role in
the control of gene expression46, several researches had
reported that the promoter regions methylation affects
the regulation of gene expression by HIF-1α33,34,47. HIF-
1α could activate transcription of many target genes,
especially many oncogenes such as VEGF, erythropoietin,
C-MYC and OCT423,45. However, our results revealed
that overexpression of HIF-1α can suppress the expres-
sion of PTGIS in UM-UC-3 cells, so our following studies
focused on the relationship between CpG Methylation of
PTGIS promoter region and transcriptional regulation of
HIF-1α on PTGIS. As shown in Fig. 6a, MethHc database
showed that PTGIS has a high DNA methylation levels in
BCa compared with normal samples, and its DNA
methylation was negatively correlated with PTGIS mRNA
expression levels in BCa (Supplementary Figure S1G). In
addition, UCSC Genome Browser database (http://
genome.ucsc.edu/) indicated that PTGIS gene promoter
region has a CpG island (Position: chr20: 49567657-
49568296), which was displayed in Fig. 5c.
In order to conﬁrm the methylation of PTGIS gene
promoter in BCa cell lines, Bisulﬁte sequence analyses
were performed in three cell lines (SV-HUC-1, UM-UC-3
and 5637), demonstrating that methylation of all CpG
sites of PTGIS gene promoter is more frequent in BCa cell
lines (UM-UC-3 and 5637) rather than immortalized
normal uroepithelial cell line (SV-HUC-1, Fig. 6b). Apart
from downregulation in the BCa tissues, our qRT-PCR
results indicated that PTGIS expression is strikingly
reduced in BCa cell lines compared with SV-HUC-1
(Fig. 6c). Next, to further prove the methylation of PTGIS,
UM-UC-3 cells were cultured with the demethylating
agent 5-Aza-2’-deoxycytidine, and qRT-PCR detected the
restoration of PTGIS expression in BCa cells (Fig. 6d).
Then we investigated the effects of HIF-1A over-
expression on PTGIS in SV-HUC-1 cells, which have a
low PTGIS gene promoter methylation level. As shown in
Fig. 6e, in contrast with transcriptional suppression in
UM-UC-3 cells, transfection of HIF-1A overexpression
plasmids could upregulate the expression level of PTGIS.
Besides, when UM-UC-3 cells were pre-treated with 5Aza
(1 µM for 24 h), the previous transcriptional suppression
would turn to transcriptional activation (Fig. 6f).
PTGIS acts as a tumor suppressor in BCa
PTGIS has been reported to be a tumor suppressor in
many kinds of cancers30–32, our results displayed that
PTGIS is downregulated both in BCa tissues (Fig. 5a) and
in BCa cell lines (Fig. 6c). Similarly, to explore the tumor
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biological functions of PTGIS in BCa, a PTGIS expression
plasmid was constructed, and the overexpression efﬁ-
ciency was veriﬁed by Western blot (Supplementary Fig-
ure S1H). As shown in Fig. 7a, b, MTT assay and
clonogenic survival assay demonstrated that
overexpression of PTGIS could suppress BCa cells pro-
liferation Moreover, the protein level of PPAR-γ was
increased by transfection of PTGIS expression plasmids
(Fig. 7d). In addition, transwell migration assay showed
that PTGIS overexpression could signiﬁcantly suppress
Fig. 5 HIF-1α suppresses the expression of PTGIS in BCa cells by binding to HRE sequence of the PTGIS promoter region. a qRT-PCR analysis
exhibited the expression of HIF-1A and PTGIS at the transcription level in BCa tissues compared with paracancerous tissues (n= 20). b qRT-PCR
analysis, Western blot analysis and immunoﬂuorescence staining (HIF-1α: red, PTGIS: green) for the effects on the PTGIS expression levels of HIF-1A
overexpression. c The schematic representation of the PTGIS promoter region. HRE (5′-ccACGTGc-3′, −292 to −285), Exon 1 (−127 to 0), and
translation start site (ATG, −72) are indicated on the genomic PTGIS sequence. The gray box represents the UCSC CpG island (−513 to 126) of PTGIS
promotor region, the black box represents the bisulﬁte sequence region (−422 to −166) of CpG island. The thick truncated lines (P1-P7) mark the
regions covered by primer sets of CHIP PCR. d The binding site of HIF-1α provided by the JASPAR database. e The ChIP assay was conducted to
analyze the local enrichment of FLAG-tagged HIF-1α across the PTGIS promote region in FLAG-tagged HIF-1A transfected UMUC3 cells compared
with empty vector transfected UMUC3 cells. The relative fold enrichment was quantiﬁed by normalization to input ﬁrst, then normalized to empty
vector transfected UMUC3 cells, which is set at 1. f Luciferase assay in UM-UC-3 cells co-transfected with PTGIS luciferase reporter plasmids (pGL4.10-
PTGIS luciferase vector, pGL4.10-PTGIS HRE mutant luciferase vector or pGL4.10 base vector), and HIF-1A overexpression plasmid or empty vector.
Values represent the mean ± SD of three independent experiments
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migration of BCa cells (Fig. 7c), while Western blot results
further proved that PTGIS overexpression could suppress
the EMT in UM-UC-3 and 5637 cell lines (Fig. 7e).
PTGIS knockdown could partially rescue the inhibition of
migration and proliferation in siCIRBP treated BCa cells
Since CIRBP could induce expression of HIF-1α, and
HIF-1α could suppress the expression of PTGIS in BCa
cells, we ﬁnally explored the regulation relationship of
CIRBP on PTGIS expression. As shown in Fig. 7f,
knockdown of CIRBP could promote the expression of
PTGIS, while overexpression of CIRBP have no obvious
suppression effect on PTGIS expression, which may be
associated with its low expression in BCa cells, and qRT-
PCR analysis demonstrated the same results in mRNA
levels (Supplementary Figure S1I). In addition, further
studies showed that PTGIS knockdown could signiﬁcantly
rescue the inhibition of migration in siCIRBP treated BCa
cells (Fig. 7g), and partial rescue of proliferation inhibition
was also observed (Fig. 7h), while PTGIS inhibition have
no effect on siCIRBP induced inhibition of clonogenic
survival ability in BCa cells (Supplementary Figure S1J).
The knockdown efﬁciency of siPTGIS was validated by
Western blot (Supplementary Figure S1K).
Discussion
Recently, CIRBP has been reported to act as an onco-
gene in many studies9,10,43,48, in this study, we investigated
the involvement of CIRBP in BCa. Our results indicated
that CIRBP is overexpressed in 57% BCa tissues and BCa
cell lines, and CIRBP could promote BCa cells prolifera-
tion and migration both in vitro and in vivo. Furthermore,
we demonstrated that CIRBP expression led to an
increase in the phosphorylation state of ERK1/2 and p38,
also promoted the EMT in BCa cells. MAPKs plays a
central role in cell proliferation control49, our tran-
scriptome data also indicated that MAPK signaling
pathways play a key role in BCa40,41, in agreement with
our results, evidence of a possible linkage between CIRBP
and MAPK signaling pathways comes from two studies,
Artero-Castro et al. reported that CIRBP displayed the
ability to bypass replicative senescence through activation
Fig. 6 CpG Methylation of PTGIS promoter region plays an important role in transcriptional regulation of HIF-1α. a MethHc database
showed that PTGIS has a high DNA methylation levels in BCa compared with normal samples. b Bisulﬁte sequence analyses of 36 CpG sits of PTGIS
promotor region in two BCa cell lines (UM-UC-3 and 5637) and immortalized normal uroepithelial cell line (SV-HUC-1). c qRT-PCR analysis detected
the mRNA level of PTGIS in distinct malignancy BCa cells (T24, UM-UC-3, 5637, BIU-87) and immortalized normal uroepithelial cell line (SV-HUC-1). d
qRT-PCR analysis detected the mRNA level of PTGIS in UM-UC-3 cells after the treatment by the demethylating agent 5-Aza (Cayman Chemical
#11166-5) at 0, 0.5 and 1 μM for 24 h. e qRT-PCR analysis detected the effects of HIF-1A overexpression on PTGIS in SV-HUC-1 cells. f qRT-PCR analysis
detected the effects of HIF-1A overexpression on PTGIS in demethylating UM-UC-3 cells (pre-treatment with 1 µM 5Aza for 24 h)
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of the ERK1/2 signaling pathway in primary mouse
embryonic ﬁbroblasts7, the second study by Lee et al.
showed that CIRBP could promote epithelial to
mesenchymal transition by activating ERK and p38
pathways43.
RNA-binding proteins play an essential role in RNA
metabolism50, CIRBP has been reported to regulate sev-
eral target genes by speciﬁcally binding to the 3′-UTR of
its target mRNAs. For instance, CIRBP could bind to the
TRX 3′-UTR and stabilize the transcript to increase its
translation16, another study showed that CIRBP could
increase the stability of pro-inﬂammatory cytokine
mRNAs under cold conditions to induce an airway
inﬂammatory response11. The results of our study showed
that CIRBP could induce HIF-1α protein production via a
CIRBP-mediated increase in mRNA stability in BCa, and
Fig. 7 Overexpression of PTGIS suppresses BCa cells proliferation and migration in vitro, increases the protein level of PPARγ and
suppresses EMT. PTGIS knockdown could partially rescue the inhibition of migration and proliferation in siCIRBP-treated BCa cells. a After
transfection with PTGIS overexpression plasmid, cell proliferation was performed by MTT assay. b Clonogenic survival assay and statistical analysis of
the clone number. c Transwell migration assay and the statistical analysis of relative cell number of migration. d, eWestern blot analysis of PPARγ and
EMT markers (E-cadherin, N-cadherin, Vimentin and β -catenin) after 48 h transfection of PTGIS overexpression plasmid. f Western blot analysis of
CIRBP, HIF-1α and PTGIS expression in siCIRBP-treated cells as well as in cells over-expressing CIRBP. g, h Rescue experiment of siPTGIS: Transwell
migration assay and MTT assay
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the same results had been reported in Melanoma LOX-
IMVI cells in a study by Chang et al51. Combined with the
RIP and biotin pull-down assay results, we calculate that
this induction was through the way of speciﬁcally binding
to the 3′-UTR of HIF-1A mRNA transcripts. HIF-1α plays
a critical role in regulation of gene transcription as a
response to hypoxia, several key regulatory steps partici-
pate in the mechanism by which changes in oxygen
concentration can be directly transduced into changes in
gene expression by HIF-1α52. Under normoxic conditions,
HIF-1α proteins are rapidly ubiquitylated and degraded by
the von Hippel-Lindau, and this process depends on the
availability of O2
53, besides, HIF-1α transcriptional activ-
ity is suppressed under normoxic conditions by hydro-
xylation of an asparagine residue within its C-terminal
transactivation domain, which is mediated by factor-
inhibiting HIF1 (FIH1)54. Our results also showed that
CIRBP could increase mRNA stability and protein trans-
lation of HIF-1α in BCa cell line, this may be part of
reason why HIF-1α could be induced under hypoxia
conditions.
HIF-1α dependent regulations in gene expression
usually involve the activation of transcription, especially
activate many oncogenes in cancers23,52, two publications
have reported that PTGIS may be an important target
gene of HIF-1α28,44. Our results ﬁrstly indicated that HIF-
1α could transcriptionally suppress the expression of
PTGIS in BCa cells through binding to HRE sequence of
the PTGIS promoter region. Further studies demon-
strated that PTGIS promoter is hypermethylated in BCa,
what’s more, overexpression of HIF-1A could increase the
expression of PTGIS in SV-HUC-1 cells, which have a low
PTGIS gene promoter methylation level. Similarly, after
culturing with the demethylating agent, the previous
transcriptional suppression would turn to transcriptional
activation in BCa cells. Our research clariﬁed that
methylation of PTGIS gene promoter may be an impor-
tant reason why PTGIS expression is downregulated by
HIF-1α but not upregulated by it in BCa cell line. A few
studies have reported the transcriptional suppression of
HIF-1α on target genes promoter activity. A study by
Chen et al. showed that HIF-1α transcriptionally
Fig. 8 Mechanism diagram. Our study demonstrated that CIRBP could promote BCa cells proliferation and migration both in vitro and in vivo.
Furthermore, CIRBP could increase HIF-1α expression by binding to the 3′-UTR of HIF-1A mRNA transcripts and increasing its mRNA stability in BCa
cell line. HIF-1α could activate transcription of many oncogenes, such as VEGF, C-MYC, and OCT4. Our results showed that PTGIS is a HIF-1α target
gene, which could suppress BCa cells proliferation and migration, and overexpression of HIF-1A could suppress the expression of PTGIS in BCa cells
by binding to HRE sequence (5′-ccACGTGc-3′) of the PTGIS promoter region. Moreover, methylation of PTGIS gene promoter may be an important
reason why PTGIS expression is downregulated by HIF-1α. And DNA methylation is also an important reason for obvious downregulation of PTGIS in
BCa
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suppressed cad-gene expression under hypoxia55, another
study by Mazure et al. displayed that the existence of a
possible competition between HIF-1α and c-Myc that
could modulate the transcriptional activity of the AFP
gene in response to hypoxia, which resulted in a sup-
pression effect of hypoxia on AFP gene expression56.
More researches are needed to explore the detailed
mechanism for transcriptional suppression of HIF-1α on
PTGIS expression in BCa.
Many studies have reported that PTGIS acted as a
tumor suppressor in several cancers30–32, our microarray
analysis (GEO accession No. GSE76211) revealed that
PTGIS is signiﬁcantly downregulated in BCa tissues, and
qRT-PCR analysis results proved this conclusion. In
addition, we proved that PTGIS overexpression could
suppress the BCa cells proliferation and migration, toge-
ther with our demonstration that PTGIS increased the
protein level of PPAR-γ and suppressed EMT, we
demonstrated that PTGIS also acts as a tumor suppressor
in BCa. MethHc database showed that PTGIS promotor
methylation was negatively correlated with PTGIS mRNA
expression levels in BCa, this indicated that DNA
methylation is an important reason for obvious down-
regulation of PTGIS in BCa. In contrast, GEPIA database
(http://gepia.cancer-pku.cn/) showed no correlation
between HIF-1A and PTGIS expression (Supplementary
Figure S1L), indicating that HIF-1A upregulation in BCa
may be a part reason for the downregulation of PTGIS.
Taken together, as shown in mechanism diagram
(Fig. 8), our study demonstrated that CIRBP acts as an
oncogene during BCa progression, which could promote
BCa cells proliferation and migration both in vitro and
in vivo. Furthermore, CIRBP could increase HIF-1α
expression by binding to the 3′-UTR of HIF-1A mRNA
transcripts and increasing its mRNA stability in BCa cell
line. In addition, PTGIS is a HIF-1α target gene, which
could suppress BCa cells proliferation and migration, and
overexpression of HIF-1A could suppress the expression
of PTGIS in BCa cells by binding to methylated HRE
sequence (5′-ccACGTGc-3′) of the PTGIS promoter
region. what’s more, further result suggested that knock-
down of CIRBP could promote the expression of PTGIS,
meanwhile knockdown of PTGIS could partially rescue
siCIRBP induced inhibition of migration and proliferation
in BCa cells
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